← Back to Search

Neuromodulation Device

Therapy Arm for Dry Eye Syndrome

Phase 4
Waitlist Available
Research Sponsored by Olympic Ophthalmics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Dry eye
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

iTEAR generation 2 will be supplied t eligible subjects at Day 0. At Day 30, symptom questionnaires and ophthalmic exam will be performed.

Eligible Conditions
  • Dry Eye Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Schirmer score
Secondary outcome measures
Symptom Scores

Trial Design

1Treatment groups
Experimental Treatment
Group I: Therapy ArmExperimental Treatment1 Intervention
Patient receive iTEAR100 treatment

Find a Location

Who is running the clinical trial?

Olympic Ophthalmics, Inc.Lead Sponsor
3 Previous Clinical Trials
335 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025